Streetbeat News

Earnings

ON Semiconductor Corp (NASDAQ: ON) reported a fiscal Q2 2024 revenue decline of 17.2% year-on-year to $1.74 billion, beating the analyst consensus estimate of $1.73 billion. The adjusted EPS of $0.96 also beat the consensus estimate of $0.92. Despite declines in various segments, the company generated $207.7 million in free cash flow and held $2.68 billion in cash and equivalents. CEO Hassane El-Khoury highlighted gains in the automotive sector and a strong Q3 outlook. The stock gained 7.84% premarket following the earnings report.

Portfolio Pulse from Anusuya Lahiri

July 29, 2024 | 12:44 pm

CNA

CNA Financial shares are trading higher following better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:42 pm

CHTR

Charter Communications Inc (NASDAQ:CHTR) reported better-than-expected Q2 2024 financial results, with revenue and EPS surpassing analyst estimates. Despite losing residential Internet and video customers, the stock gained 16.6%. Analysts have raised their price targets for the stock.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 12:39 pm

CZWI

Citizens Community (NASDAQ:CZWI) reported Q2 2024 adjusted earnings per share (EPS) of $0.35, surpassing the analyst consensus estimate of $0.27 by 29.63%.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:36 pm

Loews shares are trading higher following Q2 earnings.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:36 pm

BMRC

COLB

HIG

KEY

ZION

Five financial stocks, Columbia Banking System Inc (COLB), Hartford Financial Services Group Inc (HIG), KeyCorp (KEY), Zions Bancorporation (ZION), and Bank of Marin Bancorp (BMRC), are identified as potentially overbought with high RSI values, indicating a possible short-term price decline.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 12:33 pm

IJH

STX

XOM

On CNBC's 'Halftime Report Final Trades,' analysts discussed their top stock picks including Morgan Stanley, iShares Core S&P Mid-Cap ETF, Exxon Mobil, and Seagate Technology. Morgan Stanley reported strong Q2 earnings, Exxon Mobil is close to its all-time high and will release its Q2 results soon, and Seagate reported better-than-expected Q4 results.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 12:32 pm

PFE

Pfizer Inc. (NYSE:PFE) is set to release its Q2 earnings, with analysts expecting a drop in EPS from 67 cents to 46 cents, but a slight increase in revenue to $13.02 billion. The European Commission has approved Pfizer's gene therapy DURVEQTIX for hemophilia B. Pfizer's dividend yield stands at 5.46%, translating to a quarterly dividend of 42 cents per share. Investors would need approximately $109,880 worth of Pfizer shares to earn $500 monthly from dividends.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 12:25 pm

ABT

EZPW

GPRK

IART

ICL

IMMP

IOVA

NAMS

PDD

Several major stocks, including Abbott Laboratories, Integra LifeSciences, and NewAmsterdam Pharma, experienced significant declines in Monday's pre-market session. Abbott fell due to a $495 million damages order, Integra LifeSciences dropped after lowering its FY24 outlook, and NewAmsterdam Pharma declined following Phase 3 trial results.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 12:24 pm

LGVN

LIPO

PHG

Market-Moving News for July 29th includes significant updates from Longeveron, Koninklijke Philips, and Lipella Pharmaceuticals. Longeveron announced positive results from its Phase 2a clinical trial for Lomecel-B in mild Alzheimer's disease. Koninklijke Philips reported better-than-expected Q2 2024 earnings and sales. Lipella Pharmaceuticals commenced a Phase 2a trial for LP-310 in oral lichen planus and enrolled its first patients.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:22 pm